GALECTIN THERAPEUTICS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $893.0K | $39.6M |
| FY2022 | — | $-33.9M | $18.6M |
| FY2023 | — | $-62.0M | $25.7M |
| FY2024 | — | $-104.8M | $15.1M |
| FY2025 | — | $-127.9M | $17.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $893.0K | $39.6M |
| FY2022 | — | $-33.9M | $18.6M |
| FY2023 | — | $-62.0M | $25.7M |
| FY2024 | — | $-104.8M | $15.1M |
| FY2025 | — | $-127.9M | $17.7M |